Bone Biologics Corporation filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Weinberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | +1.67% |
|
+0.83% | -73.01% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.01% | 1.34M | |
+11.63% | 127B | |
-8.94% | 10.76B | |
-18.88% | 7.06B | |
+49.68% | 6.5B | |
-34.01% | 3.99B | |
+8.39% | 3.44B | |
-20.19% | 2.45B | |
-19.41% | 1.89B | |
-20.90% | 1.75B |
- Stock Market
- Equities
- BBLG Stock
- News Bone Biologics Corporation
- Bone Biologics Corporation Auditor Raises 'Going Concern' Doubt